Treatment of poor linear growth in a patient with osteogenesis imperfecta type III

Clinical Therapeutics

Volumn 26, Issue 10, 2004, Pages 1680-1683

  Robinson, Renee F ^a,b,c,d   Long, Lynn D ^c   Mahan, John D ^a,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b The Heart Center   (United States)

^c Div Nephrology Columbus C   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

growth; Growth hormone; skeletal dysplasia

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BONE DENSITY; BONE DISEASE; BONE GROWTH; BONE MINERAL; CASE REPORT; CONNECTIVE TISSUE DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; FRACTURE; GROWTH RATE; HEMATOLOGY; HUMAN; LONG TERM CARE; MALE; OSTEOGENESIS IMPERFECTA; PARAMETER; SCHOOL CHILD; STANDARD; TREATMENT OUTCOME;

BONE DENSITY; CHILD; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOGENESIS IMPERFECTA; TREATMENT OUTCOME;

EID: 10444234265     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.10.005     Document Type: Article

References (14)

1. Sillence D.O., Senn A., and Danks D.M. Genetic heterogeneity in osteogenesis imperfecta J Med Genet 16 1979 101 116
2. Antoniazzi F., Mottes M., and Fraschini P. Osteogenesis imperfecta: Practical treatment guidelines Paediatr Drugs 2 2000 465 488
3. Astrom E., and Soderhall S. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta Acta Paediatr 87 1998 64 68
4. Gonzalez E., Pavia C., and Ros J. Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta J Pediatr Endocrinol Metab 14 2001 529 533
5. Marini J.C., Bordenick S., and Heavner G. Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta Am J Med Genet 45 1993 261 264
6. Szulc P., Seeman E., and Delmas P.D. Biochemical measurements of bone turnover in children and adolescents Osteoporos Int 11 2000 281 294
7. Antoniazzi F., Bertoldo F., and Mottes M. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis J Pediatr 129 1996 432 439
8. Marini J.C., Bordenick S., and Heavner G. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta J Clin Endocrinol Metab 76 1993 251 256
9. Kodama H., Kubota K., and Abe T. Osteogenesis imperfecta: Are fractures and growth hormone treatment linked? J Pediatr 132 1998 559 560
10. Lindsay R., Feldkamp M., and Harris D. Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency J Pediatr 125 1994 29 35
11. Kanaka-Gantenbein C. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton) J Pediatr Endocrinol Metab 14 2001 17 26
12. Byers P.H. Osteogenesis imperfecta: Perspectives and opportunities Curr Opin Pediatr 12 2000 603 609
13. Wright N.M. Just taller or more bone? The impact of growth hormone on osteogenesis imperfecta and idiopathicjuvenile osteoporosis J Pediatr Endocrinol Metab 13 2000 999 1002
14. Astrom E., and Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta Arch Dis Child 86 2002 356 364